Navigation Links
Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
Date:9/5/2007

- Company Will Present Seven Posters and sponsor Satellite Symposium at Key

Scientific Gathering at McCormick Place in Chicago, September 17

- 20 -

CHICAGO, Sept. 5 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS), will present seven posters on selected cethromycin therapeutic studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) at McCormick Place in Chicago, September 17 - 20. ICAAC, a key scientific event expected to attract more than 12,000 scientists from around the world, is a gathering of leading researchers and clinicians to discuss important themes and present the newest treatment advances in infectious disease. The Advanced Life Sciences booth, #643, will be located in Hall D in the Lakeside Center at McCormick Place.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050428/CGTH039LOGO)

The Advanced Life Sciences poster presentations will discuss in vitro activity of cethromycin against key susceptible and resistant pathogens involved in community acquired pneumonia (CAP) as well as safety data in certain special clinical populations. Along with collaborators such as the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Eurofins Medinet, Micromyx and Battelle, the Company will present data demonstrating the potency of cethromycin against pathogens involved in bioterrorism.

In addition, Advanced Life Sciences is sponsoring a satellite symposium entitled "Drug Resistant CAP, Current and Future Treatments: Best Practices for Prevention and Management". The panel, moderated by Ge
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
3. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
4. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
5. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
6. Progenics and Wyeth Announce Positive Results from Three-Month Clinical-Extension Study of Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness
7. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
8. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
9. Advanced Viral Research Corp. Announces Positive Preliminary Findings from Ongoing Phase II Dermatological Study
10. Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
11. Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)..., BEDFORD, Mass., Nov. 9 /PRNewswire-FirstCall/ -... HOLX ), a leading developer, manufacturer and sup...ems and surgical products dedicated to serving the...sults for the fourth quarter and fiscal year ended...nounced the Board of Directors has promoted Robert...
(Date:11/9/2009)..., MAARSSEN, Netherlands, Nov. 9 ...g in Mumbai of the third CPhI India and second P-M...gies event. A combined total of over 600 exhibit... Bombay Exhibition Centre for the 2009 events, bei...igh quality exhibitors, the 2009 events include tw...
(Date:11/9/2009)..., WOODCLIFF LAKE, N.J., Nov. 9 /PRNewswire-FirstC... PRX ) today announced that it has extended the ex...its previously announced "Modified Dutch Auction" ..., for cash, up to $65,000,000 aggregate principal ...anding 2.875% Senior Subordinated Convertible Note...
Breaking Medicine Technology:Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 2Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 3Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 4Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 5Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 7Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 8Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 9Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 10Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 11Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 12Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 13Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 14Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 15Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 16Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 17Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 18Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 19Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 20Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 21Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 22Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 23Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 24Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 25Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 26Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 27Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 28Forecast Looks Good for India Pharma Shows 2Forecast Looks Good for India Pharma Shows 3Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note 2Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note 3BET News Presents Critical Condition 3A Whats At Stake In Health Care Reform Sunday September 27 at 10 PM 58300 1BET News Presents Critical Condition 3A Whats At Stake In Health Care Reform Sunday September 27 at 10 PM 58300 2BET News Presents Critical Condition 3A Whats At Stake In Health Care Reform Sunday September 27 at 10 PM 58300 3aTyr Pharma to Present at Japan Biopharma Partnering Conference 58295 1aTyr Pharma to Present at Japan Biopharma Partnering Conference 58295 2Use of statins favors the wealthy creating new social disparities in cholesterol 58291 1
..., Mass., Oct. 26 Coley,Pharmaceutical Group, Inc....y,has received a $3.0 million milestone payment fr...ation of GSK,s Phase III clinical trial in,non-sma...c cancer vaccine,containing Coley,s VaxImmune(TM) ... launch of the largest Phase III,clinical trial in...
...ownsizing non-clinical workforce, BOULDER, Colo.,... TPPH ), announced today a plan to focus all,of it...eviously announced,clinical trials. As part of the... base by 28 percent. The Company expects to elimin...tive employees in all areas of operations.,All cli...
Other Medicine Technology:Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline 2Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline 3Tapestry Announces Strategy to Focus on TPI 287 Clinical Program 2Tapestry Announces Strategy to Focus on TPI 287 Clinical Program 3Tapestry Announces Strategy to Focus on TPI 287 Clinical Program 4
(Date:11/9/2009)...esses of all sizes looking to fast-track preparedn...e a new resource at their disposal. , ... -- Human resource (HR) professionals looking to f...e H1N1 pandemic have a new resource at their dispo...r Infectious Disease Research and Policy (CIDRAP),...
(Date:11/9/2009)...on Promise. Now Is Time for Senate to Act ,, W...ollowing is a statement by Anna Burger, Chair, Cha...d decades of delay, the U.S. House of Representati...c reform legislation to assure every American, reg...affordable health care. The House,s action this No...
(Date:11/9/2009)... The House version of health care r...t , which passed by a vote of 220-215 on Saturday,...hanges to the tax code and differs in many ways fr...te version, requiring extensive reconciliation to ...Tax Briefing on the tax provisions of the legisl...
(Date:11/9/2009)...swire/ -- The Churchill Centre today announced t... J.W. "Bill" Marriott for his lifelong commitment ...rket practices and fostering an open and transpare...ive his award at a ceremony and dinner on Tuesday,...otel. ,, "This is a testament to how Bill Marr...
(Date:11/9/2009)...ith drugs that inhibit estrogen, , , MO... treat breast cancer and osteoporosis eliminated c..., The drugs also cleared precancerous growths i...f cancer in mice with precancerous lesions. , T...ancer/osteoporosis drug raloxifene were given to m...
Breaking Medicine News(10 mins):Health News:New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 2Health News:New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 3Health News:Statement of Anna Burger, Chair, Change to Win, on U.S. House Vote for Health Care Reform 2Health News:CCH Briefing Details Tax Provisions of House Health Care Bill 2Health News:J.W. 'Bill' Marriott to Receive Churchill Centre Award For Leadership 2Health News:Breast Cancer Drugs May Fight Cervical Cancer, Too 2
...ER, Mass., April 13 Millstone Medical Outsourcing...phis, TN, operations,facility, located at 4740 She...over 12,000 square feet to the existing space, whi...spection, material storage, and,distribution servi...
...ON, S.C., April 13 At a time when skin cancer is,...melanoma rates in younger,females are on the upswi...ng,the Women,s Dermatologic Society (WDS) will pro... dermatologist,Marguerite Germain, MD, (Mt. Pleasa...
...E VILLAGE, Ill., April 13 Poor health,among worke...lize, impacting,their profitability and undercutti...a major study published this week in the Journal o...mployers who focus only on medical and pharmacy co...
...te University engineers think the possibilities ar...ssistant professor of chemical engineering, is lea...graphene, a recently developed carbon material tha...r years ago, this material has already shown a lar...
...a. (April 13, 2009) While the number of American... the registry still only includes 38 percent of li...by Donate Life America this year. Yet, according ...aiting organ transplants has climbed to more than ...
...Ohio, April 13 More than 130 area high school,stu...maritan Hospital this,week for the hospital,s annu...d Samaritan Hospital 101 - Introduction to Careers...om the following local high,schools: Arcanum, Bro...
Other Medicine News:Health News:Millstone Medical Outsourcing Expands Memphis Facility to Accommodate Growth 2Health News:South Carolina Dermatologists Will Serve Tennis Fans With Free Skin Checks and Sun Safety Tips 2Health News:Most Employers Underestimate Full Costs of Employee Health on Productivity 2Health News:Most Employers Underestimate Full Costs of Employee Health on Productivity 3Health News:Most Employers Underestimate Full Costs of Employee Health on Productivity 4Health News:Most Employers Underestimate Full Costs of Employee Health on Productivity 5Health News:K-State engineers create DNA sensors that could identify cancer using material only one atom thick 2Health News:While majority of Americans express interest in organ and tissue donation, few register 2Health News:Good Samaritan Hospital-Dayton Hosts Local Students to Explore Health Careers, Learn Human Anatomy 2
...urce is a combination instrument bringing together...l-free Vacuum Pump. It is designed to handle the r... Combines a Refrigerated Cold Trap + Oil-free Pum...connections. , TEFLON materials and ETFE-coate...
... quiet, compact, efficient vacuum source developed...-free design and TEFLON®/ETFE coated vapor pat...reduced maintenance. Unique features include a TEF...tion, and a 1-liter post-pump solvent recovery ves...
Vacuum pump, 220 V
QIAvac Multiwell
Medicine Products: